Founded in 1992 by senior executives with entrepreneurial, line operating, and bulge bracket investment banking experience.
During the month of March 2010, Avalon, as the sole placement agent, raised Frederick's of Hollywood Group Inc. $3mm in common stock and warrants.
|
|
|
| Client |
Transaction Description ($mm) |
|
| 2009 August - Cytomedix, Inc. (NYSE Alternext:GTF) |
| $1,470,000 Common Stock with Warrants - Registered Direct |
|
|
|
|
|
|
Avalon worked as the sole placement agent for Cytomedix, Inc. to raise a total of $1.42mm in common stocks with warrants via a registered direct offering with several institutional investors and current shareholders. Proceeds used for general working capital.
Cytomedix, Inc. is a biotechnology company that develops, sells and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation and angiogenesis. |
| 2009 September - Cubic Energy, Inc. (AMEX:QBC) |
| $1.8 Common Stock with Warrants - Private Placement |
|
|
|
|
|
|
Avalon worked as the sole placement agent for Cubic Energy, Inc. to raise a total of $1,788,400 in common stocks with warrants via a private placement offering with several institutional investors and current shareholders.
Cubic Energy, Inc. is an independent company engaged in the development and production of, and exploration for, crude oil and natural gas. |
| 2010 March - Frederick's of Hollywood Group Inc. (NYSE Amex: FOH) |
| $3mm Common Stock with Warrants - Private Placement |
|
|
|
|
|
|
Avalon worked as the sole placement agent for Frederick's of Hollywood Group Inc to raise a total of $3mm in common stocks with warrants with several institutional investors and current shareholders. Proceeds used for general working capital and corporate purposes.
Frederick's of Hollywood Group Inc. conducts its business through its multi-channel retail division and wholesale division selling women's intimate apparel and related products. |
| AMDL, Inc. (NYSE Alternext: ADL)* |
| $7mm Common Stock with Warrants |
|
|
|
|
|
|
AMDL, Inc. (NYSE Alternext: ADL) Worked with the management team to secure over $7mm in common stock with warrants equity financing from several institutional investors to expand AMDL's over the counter generic drug and beauty cosmetics product divisions. (*) Spencer Clarke LLC was Co-placement agent.
AMDL, Inc.is a vertically integrated specialty pharmaceutical company with three distinct business divisions that include In-Vitro diagnostics, China-based pharmaceutical manufacturing and distribution and cancer therapeutics. These business units focus on the development, manufacturing, distribution and sales of medical diagnostic products, generic pharmaceuticals, nutritional supplements, and cosmetics in the United States, China, Korea, Taiwan and other markets. |
| Chembio Diagnostics (OTCBB:CEMI)* |
| $1.0mm out of $8.15mm Convertible Preferred Stock with Warrants - Private Placement |
|
|
|
|
|
|
Chembio Diagnostics (OTCBB:CEMI) Avalon's Capital Markets Co-President worked with the management to raise $1.0mm in convertible preferred stock with warrants via private placement with several institutional investors. Proceeds used for general corporate purposes including for sales and marketing, research and development, and intellectual property, and working capital. (*) Midtown Partners & Co. was sole placement agent.
Chembio Diagnostics, Inc., along with its subsidiaries, develops, manufactures and markets diagnostic tests that detect infectious diseases. |
| Cleveland BioLabs (NASDAQ: CBLI)* |
|
Cleveland BioLabs (NASDAQ: CBLI) Consulted with company on strategic initiatives including organizing non deal road show, partnering and licensing opportunities and valuation analysis. (*) While employed by Spencer Clarke LLC.
Cleveland BioLabs, Inc. (CBLI) is a development-stage biotechnology company. The Company is focused on developing cancer treatment, tissue protection and biodefense drugs. |
| Cytomedix, Inc. (NYSE Alternext: GTF)* |
|
Cytomedix (NYSE Alternext: GTF) Worked with the management team to introduce the company to institutional investors and strategic advisors during a non-deal road show in New York and Chicago. Assisted with drafting investor presentation for healthcare conference while employed by Spencer Clarke LLC (*).
Cytomedix, Inc. (Cytomedix) is a biotechnology company that develops, sells and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation and angiogenesis. |
| DataLogic Intl (OTCBB:DLGI)* |
| $1.6mm Common Stock with Warrants - Private Placement |
|
|
|
|
|
|
DataLogic Intl (OTCBB:DLGI) Avalon's Capital Markets Co-Presidents worked with the management to raise a total of $1.6mm in common stock with warrants via private placement with accredited and institutional investors. Proceeds used for repayment of debt and working capital. (*)Midtown Partners & Co. was sole placement agent.
DataLogic International, Inc. (DataLogic) provides communications solutions and consulting services to a range of United States and international commercial enterprises and governmental agencies. DataLogic also provides network security, video communications, as well as Information Technology (IT) and consulting services. |
| Deer Valley (OTCBB:DVLY)* |
| $1.3mm Convertible Preferred Stock with warrants - Private Placement |
|
|
|
|
|
|
Deer Valley (OTCBB:DVLY) Avalon's Capital Markets Co-President introduced an institutional investors as part of $1.3mm Convertible Preferred Stock with warrants raised via a private placement. Proceeds used for general corporate purposes including working capital. (*)Midtown Partners & Co. was sole placement agent.
Deer Valley Corporation (Deer Valley), through its wholly owned subsidiary, Deer Valley Homebuilders, Inc. (DVH), designs and manufactures factory-built homes which are sold to a network of independent dealers, builders, developers and government agencies located primarily in the southeastern and south central regions of the United States. |
| Drinks Americas (OTCBB:DKAM)* |
| $8mm Common Stock with Warrants - Private Placement |
|
|
|
|
|
|
Drinks Americas (OTCBB:DKAM) Avalon's Capital Markets Co-Presidents worked with the management to raise $8mm in common stock with warrants via private placement from two institutional investors directed at expanding DKAM’s icon brands such as Trump Vodka and Newman’s Own both domestically and internationally. (*)Midtown Partners & Co. was sole placement agent.
Drinks Americas Holdings, Ltd. develops, produces (primarily through co-packers), markets and/or distributes alcoholic and non-alcoholic beverages for sale primarily in the continental United States and its distribution network to certain international and duty free markets. |
|
|
|
|
|
|
